The device converts 58% of incoming light into usable energy—double the efficiency of current bioelectronic power systems.
It operates wirelessly at depths up to 4 cm beneath skin tissue, enabling new types of deep-body sensors.
Human trials could begin within 3 years for glucose monitoring in diabetes patients.
Eliminating batteries reduces infection risks and lifetime costs of implant maintenance by ~70%.
The nanoplasmonic leaf maintains 80% efficiency after 1,000 hours of continuous operation—outlasting conventional biomedical batteries by 3x.